United States · FDA National Drug Code directory
Heparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-118_47596159-4f76-4ac2-984e-4d3426a04a35
- Product NDC
- 63323-118
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Heparin Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181116
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPARIN SODIUM — 5000 [USP'U]/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BLISTER PACK in 1 CARTON (63323-118-05) / 1 SYRINGE in 1 BLISTER PACK (63323-118-01) / .5 mL in 1 SYRINGE · 63323-118-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →